Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice

Lung fibrosis is a severe condition resulting from several interstial lung diseases (ILD) with different etiologies. Current therapy of ILD, especially those associated with connective tissue diseases, is rather limited and new anti-fibrotic strategies are needed. In this study, we investigated the...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 13; no. 6; p. e0196048
Main Authors Moroncini, Gianluca, Paolini, Chiara, Orlando, Fiorenza, Capelli, Chiara, Grieco, Antonella, Tonnini, Cecilia, Agarbati, Silvia, Mondini, Eleonora, Saccomanno, Stefania, Goteri, Gaia, Svegliati Baroni, Silvia, Provinciali, Mauro, Introna, Martino, Del Papa, Nicoletta, Gabrielli, Armando
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.06.2018
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Lung fibrosis is a severe condition resulting from several interstial lung diseases (ILD) with different etiologies. Current therapy of ILD, especially those associated with connective tissue diseases, is rather limited and new anti-fibrotic strategies are needed. In this study, we investigated the anti-fibrotic activity in vivo of human mesenchymal stromal cells obtained from whole umbilical cord (hUC-MSC). Adult immunocompetent C57BL/6 mice (n. = 8 for each experimental condition) were injected intravenously with hUC-MSC (n. = 2.5 × 105) twice, 24 hours and 7 days after endotracheal injection of bleomycin. Upon sacrifice at days 8, 14, 21, collagen content, inflammatory cytokine profile, and hUC-MSC presence in explanted lung tissue were analyzed. Systemic administration of a double dose of hUC-MSC significantly reduced bleomycin-induced lung injury (inflammation and fibrosis) in mice through a selective inhibition of the IL6-IL10-TGFβ axis involving lung M2 macrophages. Only few hUC-MSC were detected from explanted lungs, suggesting a "hit and run" mechanism of action of this cellular therapy. Our data indicate that hUC-MSC possess strong in vivo anti-fibrotic activity in a mouse model resembling an immunocompetent human subject affected by inflammatory ILD, providing proof of concept for ad-hoc clinical trials.
AbstractList Lung fibrosis is a severe condition resulting from several interstial lung diseases (ILD) with different etiologies. Current therapy of ILD, especially those associated with connective tissue diseases, is rather limited and new anti-fibrotic strategies are needed. In this study, we investigated the anti-fibrotic activity in vivo of human mesenchymal stromal cells obtained from whole umbilical cord (hUC-MSC). Adult immunocompetent C57BL/6 mice (n. = 8 for each experimental condition) were injected intravenously with hUC-MSC (n. = 2.5 × 105) twice, 24 hours and 7 days after endotracheal injection of bleomycin. Upon sacrifice at days 8, 14, 21, collagen content, inflammatory cytokine profile, and hUC-MSC presence in explanted lung tissue were analyzed. Systemic administration of a double dose of hUC-MSC significantly reduced bleomycin-induced lung injury (inflammation and fibrosis) in mice through a selective inhibition of the IL6-IL10-TGFβ axis involving lung M2 macrophages. Only few hUC-MSC were detected from explanted lungs, suggesting a "hit and run" mechanism of action of this cellular therapy. Our data indicate that hUC-MSC possess strong in vivo anti-fibrotic activity in a mouse model resembling an immunocompetent human subject affected by inflammatory ILD, providing proof of concept for ad-hoc clinical trials.
Lung fibrosis is a severe condition resulting from several interstial lung diseases (ILD) with different etiologies. Current therapy of ILD, especially those associated with connective tissue diseases, is rather limited and new anti-fibrotic strategies are needed. In this study, we investigated the anti-fibrotic activity in vivo of human mesenchymal stromal cells obtained from whole umbilical cord (hUC-MSC). Adult immunocompetent C57BL/6 mice (n. = 8 for each experimental condition) were injected intravenously with hUC-MSC (n. = 2.5 × 10 5 ) twice, 24 hours and 7 days after endotracheal injection of bleomycin. Upon sacrifice at days 8, 14, 21, collagen content, inflammatory cytokine profile, and hUC-MSC presence in explanted lung tissue were analyzed. Systemic administration of a double dose of hUC-MSC significantly reduced bleomycin-induced lung injury (inflammation and fibrosis) in mice through a selective inhibition of the IL6-IL10-TGFβ axis involving lung M2 macrophages. Only few hUC-MSC were detected from explanted lungs, suggesting a “hit and run” mechanism of action of this cellular therapy. Our data indicate that hUC-MSC possess strong in vivo anti-fibrotic activity in a mouse model resembling an immunocompetent human subject affected by inflammatory ILD, providing proof of concept for ad-hoc clinical trials.
Lung fibrosis is a severe condition resulting from several interstial lung diseases (ILD) with different etiologies. Current therapy of ILD, especially those associated with connective tissue diseases, is rather limited and new anti-fibrotic strategies are needed. In this study, we investigated the anti-fibrotic activity in vivo of human mesenchymal stromal cells obtained from whole umbilical cord (hUC-MSC). Adult immunocompetent C57BL/6 mice (n. = 8 for each experimental condition) were injected intravenously with hUC-MSC (n. = 2.5 x 10.sup.5) twice, 24 hours and 7 days after endotracheal injection of bleomycin. Upon sacrifice at days 8, 14, 21, collagen content, inflammatory cytokine profile, and hUC-MSC presence in explanted lung tissue were analyzed. Systemic administration of a double dose of hUC-MSC significantly reduced bleomycin-induced lung injury (inflammation and fibrosis) in mice through a selective inhibition of the IL6-IL10-TGF[beta] axis involving lung M2 macrophages. Only few hUC-MSC were detected from explanted lungs, suggesting a "hit and run" mechanism of action of this cellular therapy. Our data indicate that hUC-MSC possess strong in vivo anti-fibrotic activity in a mouse model resembling an immunocompetent human subject affected by inflammatory ILD, providing proof of concept for ad-hoc clinical trials.
Lung fibrosis is a severe condition resulting from several interstial lung diseases (ILD) with different etiologies. Current therapy of ILD, especially those associated with connective tissue diseases, is rather limited and new anti-fibrotic strategies are needed. In this study, we investigated the anti-fibrotic activity in vivo of human mesenchymal stromal cells obtained from whole umbilical cord (hUC-MSC). Adult immunocompetent C57BL/6 mice (n. = 8 for each experimental condition) were injected intravenously with hUC-MSC (n. = 2.5 × 105) twice, 24 hours and 7 days after endotracheal injection of bleomycin. Upon sacrifice at days 8, 14, 21, collagen content, inflammatory cytokine profile, and hUC-MSC presence in explanted lung tissue were analyzed. Systemic administration of a double dose of hUC-MSC significantly reduced bleomycin-induced lung injury (inflammation and fibrosis) in mice through a selective inhibition of the IL6-IL10-TGFβ axis involving lung M2 macrophages. Only few hUC-MSC were detected from explanted lungs, suggesting a "hit and run" mechanism of action of this cellular therapy. Our data indicate that hUC-MSC possess strong in vivo anti-fibrotic activity in a mouse model resembling an immunocompetent human subject affected by inflammatory ILD, providing proof of concept for ad-hoc clinical trials.Lung fibrosis is a severe condition resulting from several interstial lung diseases (ILD) with different etiologies. Current therapy of ILD, especially those associated with connective tissue diseases, is rather limited and new anti-fibrotic strategies are needed. In this study, we investigated the anti-fibrotic activity in vivo of human mesenchymal stromal cells obtained from whole umbilical cord (hUC-MSC). Adult immunocompetent C57BL/6 mice (n. = 8 for each experimental condition) were injected intravenously with hUC-MSC (n. = 2.5 × 105) twice, 24 hours and 7 days after endotracheal injection of bleomycin. Upon sacrifice at days 8, 14, 21, collagen content, inflammatory cytokine profile, and hUC-MSC presence in explanted lung tissue were analyzed. Systemic administration of a double dose of hUC-MSC significantly reduced bleomycin-induced lung injury (inflammation and fibrosis) in mice through a selective inhibition of the IL6-IL10-TGFβ axis involving lung M2 macrophages. Only few hUC-MSC were detected from explanted lungs, suggesting a "hit and run" mechanism of action of this cellular therapy. Our data indicate that hUC-MSC possess strong in vivo anti-fibrotic activity in a mouse model resembling an immunocompetent human subject affected by inflammatory ILD, providing proof of concept for ad-hoc clinical trials.
Audience Academic
Author Grieco, Antonella
Introna, Martino
Orlando, Fiorenza
Provinciali, Mauro
Svegliati Baroni, Silvia
Mondini, Eleonora
Del Papa, Nicoletta
Paolini, Chiara
Capelli, Chiara
Goteri, Gaia
Gabrielli, Armando
Agarbati, Silvia
Saccomanno, Stefania
Moroncini, Gianluca
Tonnini, Cecilia
AuthorAffiliation 3 UOS Centro di Terapia Cellulare "G. Lanzani", A.S.S.T. Papa Giovanni XXIII, Bergamo, Italy
5 AnatomiaPatologica, Dipartimento di Scienze Biomediche s e Sanità Pubblica, Università Politecnica delle Marche, Ancona, Italy
1 Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy
6 UOC Day Hospital di Reumatologia, Dipartimento di Reumatologia, ASST G. Pini-CTO, Milano, Italy
Centre National de la Recherche Scientifique, FRANCE
4 Dipartimento di Medicina Sperimentale e Clinica, Università Politecnica delle Marche, Ancona, Italy
2 Centro di Tecnologie Avanzate nell’Invecchiamento, IRCCS-INRCA, Ancona, Italy
AuthorAffiliation_xml – name: 3 UOS Centro di Terapia Cellulare "G. Lanzani", A.S.S.T. Papa Giovanni XXIII, Bergamo, Italy
– name: 5 AnatomiaPatologica, Dipartimento di Scienze Biomediche s e Sanità Pubblica, Università Politecnica delle Marche, Ancona, Italy
– name: 6 UOC Day Hospital di Reumatologia, Dipartimento di Reumatologia, ASST G. Pini-CTO, Milano, Italy
– name: 4 Dipartimento di Medicina Sperimentale e Clinica, Università Politecnica delle Marche, Ancona, Italy
– name: 1 Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy
– name: 2 Centro di Tecnologie Avanzate nell’Invecchiamento, IRCCS-INRCA, Ancona, Italy
– name: Centre National de la Recherche Scientifique, FRANCE
Author_xml – sequence: 1
  givenname: Gianluca
  orcidid: 0000-0002-0380-0105
  surname: Moroncini
  fullname: Moroncini, Gianluca
– sequence: 2
  givenname: Chiara
  surname: Paolini
  fullname: Paolini, Chiara
– sequence: 3
  givenname: Fiorenza
  surname: Orlando
  fullname: Orlando, Fiorenza
– sequence: 4
  givenname: Chiara
  surname: Capelli
  fullname: Capelli, Chiara
– sequence: 5
  givenname: Antonella
  surname: Grieco
  fullname: Grieco, Antonella
– sequence: 6
  givenname: Cecilia
  surname: Tonnini
  fullname: Tonnini, Cecilia
– sequence: 7
  givenname: Silvia
  surname: Agarbati
  fullname: Agarbati, Silvia
– sequence: 8
  givenname: Eleonora
  surname: Mondini
  fullname: Mondini, Eleonora
– sequence: 9
  givenname: Stefania
  surname: Saccomanno
  fullname: Saccomanno, Stefania
– sequence: 10
  givenname: Gaia
  surname: Goteri
  fullname: Goteri, Gaia
– sequence: 11
  givenname: Silvia
  surname: Svegliati Baroni
  fullname: Svegliati Baroni, Silvia
– sequence: 12
  givenname: Mauro
  surname: Provinciali
  fullname: Provinciali, Mauro
– sequence: 13
  givenname: Martino
  surname: Introna
  fullname: Introna, Martino
– sequence: 14
  givenname: Nicoletta
  surname: Del Papa
  fullname: Del Papa, Nicoletta
– sequence: 15
  givenname: Armando
  surname: Gabrielli
  fullname: Gabrielli, Armando
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29856737$$D View this record in MEDLINE/PubMed
BookMark eNqNk9tq3DAQhk1JaZJt36C0hkJpL3Yr27Jk9aIQQg8LKYGeboUsy7taZMmR5NC8fcddJ6xDKEUXkkbf_KMZaU6TI-usSpLnGVplBc3e7dzgrTCrHswrlDGCcPUoOclYkS9Jjoqjg_VxchrCDqGyqAh5khznrCoJLehJEr-qoKzc3nTCpCF6N85SGRPSFjbpduiETYeu1kbL8cj5Ju29ulY2pnGr0gaWxvXduHdtaga7SVtdexd0SLVNddcN1knX9SqOTKelepo8boUJ6tk0L5Kfnz7-OP-yvLj8vD4_u1hKWlZxqUidSYLrmuGa5FLloqIYCYExFU0rSA4pt0zmWJG2RQ0rK5ZT1FLcMMkALBbJy71ub1zgU8ECzxFmZcZyKMciWe-Jxokd773uhL_hTmj-1-D8hgsftTSKE1E0jUBUEAS3oLQWEDqnjIoSVUVJQOvDFG2oO9VIyNYLMxOdn1i95Rt3zUsG_mgUeDMJeHc1qBB5p8P4FsIqN0z3LsuqwoC-uoc-nN1EbQQkoG3rIK4cRflZiTPIgxUMqNUDFIxGwWPB72o12GcOb2cOwET1O27EEAJff__2_-zlrzn7-oDdKmHiNjgzRO1smIMvDit9V-Lbbw0A3gMS_mHwqr1DMsTH7rktFx-7h0_dA27v77lJHcUYHiqizb-d_wCUTyFp
CitedBy_id crossref_primary_10_1038_s41598_019_43638_0
crossref_primary_10_1186_s13287_022_02746_x
crossref_primary_10_1155_sci_9445735
crossref_primary_10_1002_art_41267
crossref_primary_10_1186_s13287_021_02496_2
crossref_primary_10_1002_jev2_12458
crossref_primary_10_1007_s10753_024_01977_9
crossref_primary_10_1080_10520295_2020_1814966
crossref_primary_10_1186_s13287_021_02551_y
crossref_primary_10_1002_med_21594
crossref_primary_10_3389_fmed_2021_713824
crossref_primary_10_1007_s00383_019_04561_7
crossref_primary_10_1007_s10238_023_01136_8
crossref_primary_10_1186_s13287_024_03782_5
crossref_primary_10_1016_j_yexcr_2021_112788
crossref_primary_10_1038_s41598_022_22478_5
crossref_primary_10_3390_ijms24086948
crossref_primary_10_3390_cells10112982
crossref_primary_10_1038_s41598_020_72012_8
crossref_primary_10_3390_cells14050341
crossref_primary_10_3389_fbioe_2022_961987
crossref_primary_10_1186_s12967_021_02862_x
crossref_primary_10_1016_j_jcyt_2021_09_005
crossref_primary_10_3389_fbioe_2020_619980
crossref_primary_10_3389_fimmu_2020_609063
crossref_primary_10_3390_biomedicines10010163
crossref_primary_10_1038_s41420_023_01659_9
crossref_primary_10_3389_fphar_2023_1067422
crossref_primary_10_1186_s13287_021_02265_1
crossref_primary_10_2147_JIR_S372046
crossref_primary_10_3389_fcell_2021_639657
crossref_primary_10_3390_ma12091360
crossref_primary_10_1172_jci_insight_126982
Cites_doi 10.1016/j.bbrc.2007.01.045
10.1002/stem.1271
10.1016/j.brainres.2007.05.010
10.1002/art.39125
10.1038/s41598-017-13511-z
10.1186/s13075-015-0819-7
10.4236/abb.2014.51004
10.5966/sctm.2015-0379
10.1016/j.imlet.2015.05.017
10.1084/jem.20162152
10.1016/j.immuni.2014.06.008
10.1001/jama.2014.6368
10.1016/j.tem.2016.09.005
10.1186/ar4606
10.1007/s00441-017-2699-4
10.1073/pnas.1416121111
10.1007/s10616-014-9718-z
10.2353/ajpath.2009.080629
10.1073/pnas.1432929100
10.3892/ijmm.2013.1572
10.3389/fimmu.2012.00297
10.3389/fimmu.2015.00648
10.1002/art.39477
10.1189/jlb.1012512
10.1038/nrrheum.2013.166
10.1172/JCI59643
10.1164/rccm.201106-0965OC
10.1016/j.scr.2015.04.003
10.1016/j.matbio.2016.01.010
10.3727/096368915X688182
10.15283/ijsc16041
10.1136/annrheumdis-2016-209909
10.1016/j.jcyt.2015.11.013
10.1016/j.jtos.2015.11.004
10.4049/jimmunol.180.4.2650
10.3109/14653249.2011.563294
10.1111/j.1348-0421.1992.tb02045.x
10.1002/art.22204
10.1164/rccm.200702-326OC
10.1186/scrt216
10.1183/09059180.00003214
10.1016/j.autrev.2015.02.002
10.1016/j.transproceed.2008.01.080
10.3892/etm.2017.4222
10.1097/01.mcp.0000410742.90463.1f
10.1155/2015/816460
10.1136/jcp.41.4.467
10.1111/j.1365-2567.2008.02891.x
10.3389/fimmu.2015.00602
10.1056/NEJMoa055120
10.1182/blood-2010-12-327353
ContentType Journal Article
Copyright COPYRIGHT 2018 Public Library of Science
2018 Moroncini et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2018 Moroncini et al 2018 Moroncini et al
Copyright_xml – notice: COPYRIGHT 2018 Public Library of Science
– notice: 2018 Moroncini et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2018 Moroncini et al 2018 Moroncini et al
DBID AAYXX
CITATION
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0196048
DatabaseName CrossRef
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
Health & Medical Collection (Alumni)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed


MEDLINE - Academic
Agricultural Science Database



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Human mesenchymal stromal cells for the therapy of lung fibrosis
EISSN 1932-6203
ExternalDocumentID 2049519205
oai_doaj_org_article_6a3dda07a6074077ba9c22797a508356
PMC5983506
A541074939
29856737
10_1371_journal_pone_0196048
Genre Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GrantInformation_xml – fundername: ;
  grantid: Grant RF-2011-02352331
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
BBORY
IPNFZ
NPM
RIG
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
-
02
AAPBV
ABPTK
ADACO
BBAFP
KM
ID FETCH-LOGICAL-c758t-e6b1c64bb94b62ce2a8740aa447adfa62604f9c24e6ff0d9589270f74d9c940a3
IEDL.DBID M48
ISSN 1932-6203
IngestDate Fri Nov 26 17:13:20 EST 2021
Wed Aug 27 01:01:35 EDT 2025
Thu Aug 21 14:07:16 EDT 2025
Tue Aug 05 10:29:30 EDT 2025
Fri Jul 25 10:25:18 EDT 2025
Tue Jun 17 21:14:25 EDT 2025
Tue Jun 10 20:30:34 EDT 2025
Fri Jun 27 03:31:10 EDT 2025
Fri Jun 27 03:47:43 EDT 2025
Thu May 22 21:22:38 EDT 2025
Thu Apr 03 07:11:30 EDT 2025
Thu Apr 24 23:07:57 EDT 2025
Tue Jul 01 03:51:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c758t-e6b1c64bb94b62ce2a8740aa447adfa62604f9c24e6ff0d9589270f74d9c940a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0002-0380-0105
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0196048
PMID 29856737
PQID 2049519205
PQPubID 1436336
PageCount e0196048
ParticipantIDs plos_journals_2049519205
doaj_primary_oai_doaj_org_article_6a3dda07a6074077ba9c22797a508356
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5983506
proquest_miscellaneous_2049555884
proquest_journals_2049519205
gale_infotracmisc_A541074939
gale_infotracacademiconefile_A541074939
gale_incontextgauss_ISR_A541074939
gale_incontextgauss_IOV_A541074939
gale_healthsolutions_A541074939
pubmed_primary_29856737
crossref_primary_10_1371_journal_pone_0196048
crossref_citationtrail_10_1371_journal_pone_0196048
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-06-01
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 06
  year: 2018
  text: 2018-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2018
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References M Wang (ref17) 2009; 126
DJ Prockop (ref5) 2016; 51
N Cimolai (ref23) 1992; 36
C Capelli (ref19) 2011; 13
RH Lee (ref21) 2014; 111
VJ Coulson-Thomas (ref2) 2016; 14
JM van Laar (ref11) 2014; 311
AC MacKinnon (ref30) 2008; 180
R Montironi (ref22) 2008; 30
SF de Witte (ref48) 2016; 6
Y Moodley (ref18) 2009; 175
RK Hoyles (ref9) 2006; 54
A Cras (ref6) 2015; 17
M Iudici (ref13) 2015; 14
P Fraticelli (ref12) 2014; 16
C Franceschi (ref52) 2017; 28
M Sanchez-Alavez (ref20) 2007; 1158
SE New (ref34) 2015; 15
M Provinciali (ref54) 2011; 17
F Zhao (ref50) 2008; 40
H Wang (ref16) 2014; 33
AV Misharin (ref43) 2017; 214
P Luz-Crawford (ref49) 2013; 4
E Eggenhofer (ref38) 2012; 3
TT Braga (ref41) 2015; 6
CR Kliment (ref26) 2011; 4
EA Ayaub (ref33) 2017; 7
Y Iso (ref47) 2007; 354
M Najar (ref1) 2016; 18
A Tyndall (ref4) 2015; 168
T Roszer (ref31) 2015; 2015
AC Mackinnon (ref32) 2012; 185
A Sica (ref27) 2012; 122
M Reddy (ref45) 2016; 9
D Bharti (ref36) 2018; 372
C Zhang (ref51) 2017; 13
T Ashcroft (ref24) 1988; 41
O Kowal-Bielecka (ref14) 2017; 76
AT Maria (ref40) 2016; 68
H Choi (ref46) 2011; 118
DC Ding (ref15) 2015; 25
LA Ortiz (ref44) 2003; 100
DP Tashkin (ref10) 2007; 176
PJ Murray (ref28) 2014; 41
A Tyndall (ref3) 2014; 10
G Moroncini (ref25) 2015; 67
AU Wells (ref7) 2009; 48
DP Tashkin (ref8) 2006; 354
R Secunda (ref35) 2015; 67
G Bagnato (ref42) 2015; 24
EG Schmuck (ref39) 2016; 5
V Sueblinvong (ref53) 2014; 5
J Nystedt (ref37) 2013; 31
ML Novak (ref29) 2013; 93
26142543 - Immunol Lett. 2015 Dec;168(2):201-7
21577320 - Int J Clin Exp Pathol. 2011 Apr;4(4):349-55
17133610 - Arthritis Rheum. 2006 Dec;54(12):3962-70
17717203 - Am J Respir Crit Care Med. 2007 Nov 15;176(10):1026-34
21551236 - Blood. 2011 Jul 14;118(2):330-8
23734780 - Stem Cell Res Ther. 2013 Jun 04;4(3):65
26089604 - Mediators Inflamm. 2015;2015:816460
17570349 - Brain Res. 2007 Jul 16;1158:71-80
27941129 - Ann Rheum Dis. 2017 Aug;76(8):1327-1339
23056000 - Front Immunol. 2012 Sep 26;3:297
17257581 - Biochem Biophys Res Commun. 2007 Mar 16;354(3):700-6
18624725 - Immunology. 2009 Feb;126(2):220-32
19497992 - Am J Pathol. 2009 Jul;175(1):303-13
26525582 - Arthritis Res Ther. 2015 Nov 03;17:301
12815096 - Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8407-11
29038604 - Sci Rep. 2017 Oct 16;7(1):13281
23505314 - J Leukoc Biol. 2013 Jun;93(6):875-81
28694385 - J Exp Med. 2017 Aug 7;214(8):2387-2404
25058083 - JAMA. 2014 Jun 25;311(24):2490-8
26779185 - Front Immunol. 2016 Jan 06;6:648
25808833 - Arthritis Rheumatol. 2015 Jul;67(7):1891-903
21417678 - Cytotherapy. 2011 Aug;13(7):786-801
3366935 - J Clin Pathol. 1988 Apr;41(4):467-70
28565787 - Exp Ther Med. 2017 May;13(5):1922-1926
26857227 - Cytotherapy. 2016 Mar;18(3):320-35
24217581 - Nat Rev Rheumatol. 2014 Feb;10 (2):117-24
23132820 - Stem Cells. 2013 Feb;31(2):317-26
27789101 - Trends Endocrinol Metab. 2017 Mar;28(3):199-212
18936524 - Cell Oncol. 2008;30(6):473-82
26804815 - Ocul Surf. 2016 Apr;14 (2):121-34
29204746 - Cell Tissue Res. 2018 Apr;372(1):51-65
25709096 - Autoimmun Rev. 2015 Jul;14(7):575-8
27460855 - Stem Cells Transl Med. 2016 Dec;5(12 ):1668-1675
22095546 - Am J Respir Crit Care Med. 2012 Mar 1;185(5):537-46
26807758 - Matrix Biol. 2016 Apr;51:7-13
26474311 - Arthritis Rheumatol. 2016 Apr;68(4):1013-25
25726561 - Eur Respir Rev. 2015 Mar;24(135):102-14
19487223 - Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii40-4
22378047 - J Clin Invest. 2012 Mar;122(3):787-95
25385603 - Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16766-71
24297321 - Int J Mol Med. 2014 Feb;33(2):263-70
1513263 - Microbiol Immunol. 1992;36(5):465-78
18250477 - J Immunol. 2008 Feb 15;180(4):2650-8
24596659 - Adv Biosci Biotechnol. 2014 Jan;5(1):19-30
26044082 - Cell Transplant. 2016;25(2):217-28
26635814 - Front Immunol. 2015 Nov 25;6:602
25035950 - Immunity. 2014 Jul 17;41(1):14-20
24798808 - Cytotechnology. 2015 Oct;67(5):793-807
25007944 - Arthritis Res Ther. 2014 Jul 08;16(4):R144
16790698 - N Engl J Med. 2006 Jun 22;354(25):2655-66
22209928 - Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S3-10
27871152 - Int J Stem Cells. 2016 Nov 30;9(2):192-206
25957945 - Stem Cell Res. 2015 Jul;15(1):1-13
18589176 - Transplant Proc. 2008 Jun;40(5):1700-5
References_xml – volume: 354
  start-page: 700
  issue: 3
  year: 2007
  ident: ref47
  article-title: Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2007.01.045
– volume: 31
  start-page: 317
  issue: 2
  year: 2013
  ident: ref37
  article-title: Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells
  publication-title: Stem Cells
  doi: 10.1002/stem.1271
– volume: 1158
  start-page: 71
  year: 2007
  ident: ref20
  article-title: Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2007.05.010
– volume: 67
  start-page: 1891
  issue: 7
  year: 2015
  ident: ref25
  article-title: Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor alpha Autoantibodies in Systemic Sclerosis
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.39125
– volume: 7
  start-page: 13281
  issue: 1
  year: 2017
  ident: ref33
  article-title: Overexpression of OSM and IL-6 impacts the polarization of pro-fibrotic macrophages and the development of bleomycin-induced lung fibrosis
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-13511-z
– volume: 17
  start-page: 301
  year: 2015
  ident: ref6
  article-title: Update on mesenchymal stem cell-based therapy in lupus and scleroderma
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-015-0819-7
– volume: 5
  start-page: 19
  issue: 1
  year: 2014
  ident: ref53
  article-title: Aging promotes pro-fibrotic matrix production and increases fibrocyte recruitment during acute lung injury
  publication-title: Adv Biosci Biotechnol
  doi: 10.4236/abb.2014.51004
– volume: 5
  start-page: 1668
  issue: 12
  year: 2016
  ident: ref39
  article-title: Biodistribution and Clearance of Human Mesenchymal Stem Cells by Quantitative Three-Dimensional Cryo-Imaging After Intravenous Infusion in a Rat Lung Injury Model
  publication-title: Stem Cells Transl Med
  doi: 10.5966/sctm.2015-0379
– volume: 168
  start-page: 201
  issue: 2
  year: 2015
  ident: ref4
  article-title: Mesenchymal stromal cells and rheumatic disorders
  publication-title: Immunol Lett
  doi: 10.1016/j.imlet.2015.05.017
– volume: 214
  start-page: 2387
  issue: 8
  year: 2017
  ident: ref43
  article-title: Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
  publication-title: J Exp Med
  doi: 10.1084/jem.20162152
– volume: 41
  start-page: 14
  issue: 1
  year: 2014
  ident: ref28
  article-title: Macrophage activation and polarization: nomenclature and experimental guidelines
  publication-title: Immunity
  doi: 10.1016/j.immuni.2014.06.008
– volume: 311
  start-page: 2490
  issue: 24
  year: 2014
  ident: ref11
  article-title: Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial
  publication-title: Jama
  doi: 10.1001/jama.2014.6368
– volume: 28
  start-page: 199
  issue: 3
  year: 2017
  ident: ref52
  article-title: Inflammaging and ‘Garb-aging’
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/j.tem.2016.09.005
– volume: 16
  start-page: R144
  issue: 4
  year: 2014
  ident: ref12
  article-title: Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar4606
– volume: 4
  start-page: 349
  issue: 4
  year: 2011
  ident: ref26
  article-title: A novel method for accurate collagen and biochemical assessment of pulmonary tissue utilizing one animal
  publication-title: Int J Clin Exp Pathol
– volume: 372
  start-page: 51
  issue: 1
  year: 2018
  ident: ref36
  article-title: Comparative analysis of human Wharton’s jelly mesenchymal stem cells derived from different parts of the same umbilical cord
  publication-title: Cell Tissue Res
  doi: 10.1007/s00441-017-2699-4
– volume: 111
  start-page: 16766
  issue: 47
  year: 2014
  ident: ref21
  article-title: TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1416121111
– volume: 67
  start-page: 793
  issue: 5
  year: 2015
  ident: ref35
  article-title: Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study
  publication-title: Cytotechnology
  doi: 10.1007/s10616-014-9718-z
– volume: 175
  start-page: 303
  issue: 1
  year: 2009
  ident: ref18
  article-title: Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2009.080629
– volume: 100
  start-page: 8407
  issue: 14
  year: 2003
  ident: ref44
  article-title: Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1432929100
– volume: 33
  start-page: 263
  issue: 2
  year: 2014
  ident: ref16
  article-title: Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantion on hyperglycemia in diabetic rats
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2013.1572
– volume: 3
  start-page: 297
  year: 2012
  ident: ref38
  article-title: Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2012.00297
– volume: 6
  start-page: 648
  year: 2016
  ident: ref48
  article-title: Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2015.00648
– volume: 68
  start-page: 1013
  issue: 4
  year: 2016
  ident: ref40
  article-title: Anti-fibrotic, anti-oxidant and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.39477
– volume: 93
  start-page: 875
  issue: 6
  year: 2013
  ident: ref29
  article-title: Macrophage phenotypes during tissue repair
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.1012512
– volume: 10
  start-page: 117
  issue: 2
  year: 2014
  ident: ref3
  article-title: Mesenchymal stem cell treatments in rheumatology: a glass half full?
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2013.166
– volume: 122
  start-page: 787
  issue: 3
  year: 2012
  ident: ref27
  article-title: Macrophage plasticity and polarization: in vivo veritas
  publication-title: J Clin Invest
  doi: 10.1172/JCI59643
– volume: 48
  start-page: iii40
  issue: Suppl 3
  year: 2009
  ident: ref7
  article-title: Pulmonary complications: one of the most challenging complications of systemic sclerosis
  publication-title: Rheumatology (Oxford)
– volume: 185
  start-page: 537
  issue: 5
  year: 2012
  ident: ref32
  article-title: Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201106-0965OC
– volume: 15
  start-page: 1
  issue: 1
  year: 2015
  ident: ref34
  article-title: A matter of identity—Phenotype and differentiation potential of human somatic stem cells
  publication-title: Stem Cell Res
  doi: 10.1016/j.scr.2015.04.003
– volume: 51
  start-page: 7
  year: 2016
  ident: ref5
  article-title: Inflammation, fibrosis, and modulation of the process by mesenchymal stem/stromal cells
  publication-title: Matrix Biol
  doi: 10.1016/j.matbio.2016.01.010
– volume: 25
  start-page: 217
  issue: 2
  year: 2015
  ident: ref15
  article-title: Characterization of HLA-G and Related Immunosuppressive Effects in Human Umbilical Cord Stroma-Derived Stem Cells
  publication-title: Cell Transplant
  doi: 10.3727/096368915X688182
– volume: 9
  start-page: 192
  issue: 2
  year: 2016
  ident: ref45
  article-title: Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone
  publication-title: Int J Stem Cells
  doi: 10.15283/ijsc16041
– volume: 76
  start-page: 1327
  issue: 8
  year: 2017
  ident: ref14
  article-title: Update of EULAR recommendations for the treatment of systemic sclerosis
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2016-209909
– volume: 18
  start-page: 320
  issue: 3
  year: 2016
  ident: ref1
  article-title: Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2015.11.013
– volume: 14
  start-page: 121
  issue: 2
  year: 2016
  ident: ref2
  article-title: Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System
  publication-title: Ocul Surf
  doi: 10.1016/j.jtos.2015.11.004
– volume: 180
  start-page: 2650
  issue: 4
  year: 2008
  ident: ref30
  article-title: Regulation of alternative macrophage activation by galectin-3
  publication-title: J Immunol
  doi: 10.4049/jimmunol.180.4.2650
– volume: 13
  start-page: 786
  issue: 7
  year: 2011
  ident: ref19
  article-title: Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate
  publication-title: Cytotherapy
  doi: 10.3109/14653249.2011.563294
– volume: 36
  start-page: 465
  issue: 5
  year: 1992
  ident: ref23
  article-title: Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection
  publication-title: Microbiol Immunol
  doi: 10.1111/j.1348-0421.1992.tb02045.x
– volume: 54
  start-page: 3962
  issue: 12
  year: 2006
  ident: ref9
  article-title: A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22204
– volume: 176
  start-page: 1026
  issue: 10
  year: 2007
  ident: ref10
  article-title: Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200702-326OC
– volume: 4
  start-page: 65
  issue: 3
  year: 2013
  ident: ref49
  article-title: Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells
  publication-title: Stem Cell Res Ther
  doi: 10.1186/scrt216
– volume: 24
  start-page: 102
  issue: 135
  year: 2015
  ident: ref42
  article-title: Cellular interactions in the pathogenesis of interstitial lung diseases
  publication-title: Eur Respir Rev
  doi: 10.1183/09059180.00003214
– volume: 14
  start-page: 575
  issue: 7
  year: 2015
  ident: ref13
  article-title: Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2015.02.002
– volume: 40
  start-page: 1700
  issue: 5
  year: 2008
  ident: ref50
  article-title: Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2008.01.080
– volume: 13
  start-page: 1922
  issue: 5
  year: 2017
  ident: ref51
  article-title: Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis: A case report
  publication-title: Exp Ther Med
  doi: 10.3892/etm.2017.4222
– volume: 17
  start-page: S3
  issue: Suppl 1
  year: 2011
  ident: ref54
  article-title: Inflammation, chronic obstructive pulmonary disease and aging
  publication-title: Curr Opin Pulm Med
  doi: 10.1097/01.mcp.0000410742.90463.1f
– volume: 2015
  start-page: 816460
  year: 2015
  ident: ref31
  article-title: Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
  publication-title: Mediators Inflamm
  doi: 10.1155/2015/816460
– volume: 41
  start-page: 467
  issue: 4
  year: 1988
  ident: ref24
  article-title: Simple method of estimating severity of pulmonary fibrosis on a numerical scale
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.41.4.467
– volume: 126
  start-page: 220
  issue: 2
  year: 2009
  ident: ref17
  article-title: The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2008.02891.x
– volume: 30
  start-page: 473
  issue: 6
  year: 2008
  ident: ref22
  article-title: Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction
  publication-title: Cell Oncol
– volume: 6
  start-page: 602
  year: 2015
  ident: ref41
  article-title: Macrophages During the Fibrotic Process: M2 as Friend and Foe
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2015.00602
– volume: 354
  start-page: 2655
  issue: 25
  year: 2006
  ident: ref8
  article-title: Cyclophosphamide versus placebo in scleroderma lung disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa055120
– volume: 118
  start-page: 330
  issue: 2
  year: 2011
  ident: ref46
  article-title: Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages
  publication-title: Blood
  doi: 10.1182/blood-2010-12-327353
– reference: 25709096 - Autoimmun Rev. 2015 Jul;14(7):575-8
– reference: 22378047 - J Clin Invest. 2012 Mar;122(3):787-95
– reference: 17570349 - Brain Res. 2007 Jul 16;1158:71-80
– reference: 29204746 - Cell Tissue Res. 2018 Apr;372(1):51-65
– reference: 27460855 - Stem Cells Transl Med. 2016 Dec;5(12 ):1668-1675
– reference: 21577320 - Int J Clin Exp Pathol. 2011 Apr;4(4):349-55
– reference: 28694385 - J Exp Med. 2017 Aug 7;214(8):2387-2404
– reference: 26857227 - Cytotherapy. 2016 Mar;18(3):320-35
– reference: 17717203 - Am J Respir Crit Care Med. 2007 Nov 15;176(10):1026-34
– reference: 26044082 - Cell Transplant. 2016;25(2):217-28
– reference: 26635814 - Front Immunol. 2015 Nov 25;6:602
– reference: 24798808 - Cytotechnology. 2015 Oct;67(5):793-807
– reference: 26089604 - Mediators Inflamm. 2015;2015:816460
– reference: 17133610 - Arthritis Rheum. 2006 Dec;54(12):3962-70
– reference: 18936524 - Cell Oncol. 2008;30(6):473-82
– reference: 25808833 - Arthritis Rheumatol. 2015 Jul;67(7):1891-903
– reference: 27871152 - Int J Stem Cells. 2016 Nov 30;9(2):192-206
– reference: 23056000 - Front Immunol. 2012 Sep 26;3:297
– reference: 26779185 - Front Immunol. 2016 Jan 06;6:648
– reference: 28565787 - Exp Ther Med. 2017 May;13(5):1922-1926
– reference: 19497992 - Am J Pathol. 2009 Jul;175(1):303-13
– reference: 21417678 - Cytotherapy. 2011 Aug;13(7):786-801
– reference: 16790698 - N Engl J Med. 2006 Jun 22;354(25):2655-66
– reference: 24297321 - Int J Mol Med. 2014 Feb;33(2):263-70
– reference: 18589176 - Transplant Proc. 2008 Jun;40(5):1700-5
– reference: 25035950 - Immunity. 2014 Jul 17;41(1):14-20
– reference: 27941129 - Ann Rheum Dis. 2017 Aug;76(8):1327-1339
– reference: 25058083 - JAMA. 2014 Jun 25;311(24):2490-8
– reference: 23734780 - Stem Cell Res Ther. 2013 Jun 04;4(3):65
– reference: 25957945 - Stem Cell Res. 2015 Jul;15(1):1-13
– reference: 17257581 - Biochem Biophys Res Commun. 2007 Mar 16;354(3):700-6
– reference: 24217581 - Nat Rev Rheumatol. 2014 Feb;10 (2):117-24
– reference: 29038604 - Sci Rep. 2017 Oct 16;7(1):13281
– reference: 18624725 - Immunology. 2009 Feb;126(2):220-32
– reference: 26474311 - Arthritis Rheumatol. 2016 Apr;68(4):1013-25
– reference: 26525582 - Arthritis Res Ther. 2015 Nov 03;17:301
– reference: 12815096 - Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8407-11
– reference: 23505314 - J Leukoc Biol. 2013 Jun;93(6):875-81
– reference: 22095546 - Am J Respir Crit Care Med. 2012 Mar 1;185(5):537-46
– reference: 25726561 - Eur Respir Rev. 2015 Mar;24(135):102-14
– reference: 24596659 - Adv Biosci Biotechnol. 2014 Jan;5(1):19-30
– reference: 1513263 - Microbiol Immunol. 1992;36(5):465-78
– reference: 19487223 - Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii40-4
– reference: 26807758 - Matrix Biol. 2016 Apr;51:7-13
– reference: 22209928 - Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S3-10
– reference: 21551236 - Blood. 2011 Jul 14;118(2):330-8
– reference: 25385603 - Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16766-71
– reference: 3366935 - J Clin Pathol. 1988 Apr;41(4):467-70
– reference: 27789101 - Trends Endocrinol Metab. 2017 Mar;28(3):199-212
– reference: 26142543 - Immunol Lett. 2015 Dec;168(2):201-7
– reference: 25007944 - Arthritis Res Ther. 2014 Jul 08;16(4):R144
– reference: 23132820 - Stem Cells. 2013 Feb;31(2):317-26
– reference: 18250477 - J Immunol. 2008 Feb 15;180(4):2650-8
– reference: 26804815 - Ocul Surf. 2016 Apr;14 (2):121-34
SSID ssj0053866
Score 2.443807
Snippet Lung fibrosis is a severe condition resulting from several interstial lung diseases (ILD) with different etiologies. Current therapy of ILD, especially those...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0196048
SubjectTerms Aging
Biology and Life Sciences
Bleomycin
Bone marrow
Cesarean section
Clinical trials
Collagen
Connective tissue diseases
Connective tissues
Etiology
Fibrosis
Health aspects
Immunocompetence
In vivo methods and tests
Inflammation
Injury prevention
Interleukin 1
Interleukin 10
Interleukin 6
Lung diseases
Lungs
Macrophages
Medical research
Medicine and Health Sciences
Mesenchymal stem cells
Mesenchyme
Mice
Prevention
Pulmonary fibrosis
Rats
Research and Analysis Methods
Stem cells
Stromal cells
Therapy
Transplants & implants
Umbilical cord
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELXQnrggylcDpRiEBBzSehPHjo8FURUkQAKKerMcx25X2iarJnvg33cm9oYNqlQOnFaKX6LdmfF4JjvzhpDXtVCZg7AjdV7kKRd8nirvZOrhbGPeQQxiBrbPr-LklH8-K862Rn1hTVigBw6COxQmr2vDpBFw2DEpK6Msst5Jg0TmxUC2DWfeJpkKPhh2sRCxUS6X88Ool4NV27gDZIRhOO9n6yAa-PpHrzxbLdvuppDz78rJraPo-D65F2NIehS--w6545oHZCfu0o6-jVTS7x6S_gs2F9mL35eA7_qrFj_xXX1Hsa-EDhP66PoSK2QtLkEqSleB1YlCaEjrPzVFtPV0Ca6Besiw227R0UVDF9he0toYfPcUh9s_IqfHH39-OEnjnIXUQrbQp05Ucyt4VSleiQwnhOGcPmM4l6b2BlMe7kHq3AnvWa2KUmWSeclrZRUA88dk1oBkdwktwQGUBqduQqajbF2xykBEMOfWepEZlpB8I3RtIwk5zsJY6uGfNQnJSJChRlXpqKqEpONdq0DCcQv-PepzxCKF9nABDEtHw9K3GVZCXqA16NCPOjoCfVRwLGJVuUrIqwGBNBoN1umcm3XX6U_ffv0D6Mf3CehNBPkWxGFN7I2A34T0XBPk3gQJzsBOlnfRdjdS6XQGGSAE6Rkr4M6NPd-8_HJcxodi7V3j2nXEFNjQnJAnwfxHyWaqLHDSUULkZGNMRD9daRYXA4t5oUDKTDz9H7p6Ru5CIFuGEr49Muuv1u45BIt9tT_4hWv_w2gN
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELagvPCCGL8WGGAQEvCQzU0cu35CAzENJEAChvoWOY69VeriUqcP_PfcJW62oAl4qhRfoubsO3_n3H1HyItaqMwC7EitE3nKBZ-mylmZOtjbmLOAQXTH9vlZHJ_wj_NiHg_cQkyr3PrEzlHX3uAZOQTpAOUBjrDizepnil2j8OtqbKFxndxA6jJM6ZLzIeACWxYilsvlcnoQZ2d_5Ru7j7wwDLv-XNqOOtb-wTdPVksfrgKef-ZPXtqQjm6TWxFJ0sN-6nfINdvcITvRVgN9FQmlX98l7ScsMTJnv85BPrRrj794Yh8oVpfQrk8f3ZxjnqzBIQhI6arndqIAEGl9kVlEvaNLcBDUQZztwyLQRUMXWGTiTYTgLcUW9_fIydH77--O09htITUQM7SpFdXUCF5Vilciwz5h2K1Pa86lrp3GwIc7ZTJuhXOsBm2rTDInea2MAsH8Ppk0oNldQmfgBmYae29CvKNMXbFKAy6YcmOcyDRLSL5VemkiFTl2xFiW3fc1CSFJr8MSp6qMU5WQdLhr1VNx_EP-Lc7nIItE2t0Fvz4to12WQud1rZnUArAUk7LS8IqZVFIjT34hEvIUV0PZV6UO7qA8LDimsqpcJeR5J4FkGg1m65zqTQjlhy8__kPo29eR0Mso5Dyow-hYIQHvhCRdI8m9kSS4BDMa3sW1u9VKKC-MB-7cruerh58Nw_hQzMBrrN9EmQLLmhPyoF_-g2YzNSuw31FC5MgwRqofjzSLs47LvFCgZSYe_v1vPSI3AajO-hS9PTJp1xv7GMBgWz3pLP431mBgkg
  priority: 102
  providerName: ProQuest
Title Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice
URI https://www.ncbi.nlm.nih.gov/pubmed/29856737
https://www.proquest.com/docview/2049519205
https://www.proquest.com/docview/2049555884
https://pubmed.ncbi.nlm.nih.gov/PMC5983506
https://doaj.org/article/6a3dda07a6074077ba9c22797a508356
http://dx.doi.org/10.1371/journal.pone.0196048
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe27oUXxPhaxigGIQEPqdLEseMHhLapZSBtoEFR3yLHibdKbVKaVGIv_O3cJW4gqIi9uFJ9jpTz3fl38X0Q8jLl0s8AdriZ4YHLOBu60mTCNXC2eSYDDKLqap8X_GzCPk7D6Q7Z9Gy1DCy3unbYT2qymg9-fL95Bwr_tu7aIIabRYNlkWcDrPcCUrlL9uBsEqiq56y9VwDtrm8vEbW43PcCm0z3r6d0Dqu6pn9ruXvLeVFug6V_R1f-cVyN75G7FmfS40Yw9slOlt8n-1aTS_ralpt-84BU55iApK9vFkBfVqsCf_F7fkkx94TWXfzoeoFRtBqnwF2ly6byEwX4SNPfcUe0MHQO5oMa8MKLclbSWU5nmIJSaAvQK7oA2_SQTMajr6dnru3F4GrwKCo348lQc5YkkiXcxy5i2MtPKcaESo1Ct4gZqX2WcWO8VIaR9IVnBEullkAYPCK9HDh7QGgERiJS2JkTvCGp08RLFKCGIdPacF95Dgk2TI-1LVSO_TLmcX37JsBhaXgY41bFdqsc4rarlk2hjv_Qn-B-trRYZrv-o1hdxVZrY66CNFWeUByQlidEouAVfSGFwir6IXfIM5SGuMlZbY1FfBwyDHSVgXTIi5oCS23kGMtzpdZlGX_49O0WRF8uO0SvLJEpgB1a2fwJeCcs4dWhPOpQgsHQnekDlN0NV8rYBy8RgLzvhbByI8_bp5-30_hQjM_Ls2JtaUJMenbI40b8W876MgqxG5JDREcxOqzvzuSz67rSeSiByx4_vA1_npA7AGajJozviPSq1Tp7CoCxSvpkV0wFjNHpEMfx-z7ZOxldfL7s159g-rWNwPHn6BdyDHCq
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKcoBLRXk1pVCDQMAhJZs49vqAUHlUu_SBBG21t-A4cbvSbrJsskL9U_xGZhInbVAFXHqKtP4SJePx-Jv1PAh5nnDpp0A73NTwwGWc9V1pUuEa2Ns8kwIHUVW1z0M-PGafx-F4hfxqcmEwrLKxiZWhTnKN_5GDkw5UHuiIF76b_3CxaxSerjYtNGq12EvPf4LLVrwdfYT5feH7u5-OPgxd21XA1cCNSzflcV9zFseSxdzHfljYlU4pxoRKjEKCz4zUPku5MV4iw4H0hWcES6SWAAzguTfITdh4PVxRYtw6eGA7OLfpeYHov7HasD3Ps3Qb69B42GXo0vZXdQlo94LefJoXVxHdP-M1L22Au3fIqmWudKdWtTWykmZ3yZq1DQV9ZQtYv75HygNMadJn5zPAF-UixyueEBQUs1lo1ReQLmcYl6txCKRJ53UtKQqElCYXkUw0N3QKBoka8OvzYlLQSUYnmNSSa0v5SzoDa3efHF_LPDwgvQwku07oAMzOQGGvT_CvpE5iL1bAQ_pMa8N95TkkaIQeaVv6HDtwTKPqPE-AC1TLMMKpiuxUOcRt75rXpT_-gX-P89lisXB39UO-OI2sHYi4CpJEeUJx4G6eELGCT_SFFArr8ofcIVuoDVGdBduan2gnZBg6KwPpkGcVAot3ZBgddKqWRRGNvpz8B-jb1w7opQWZHMShlc3IgG_ComAd5GYHCSZId4bXUXcbqRTRxWKFOxt9vnr4aTuMD8WIvyzNlxYTYhq1Qx7W6t9K1peDEPsrOUR0FkZH9N2RbHJW1U4PJUjZ4xt_f60tcmt4dLAf7Y8O9x6R20CSB3V44CbplYtl-hiIaBk_qVY_Jd-v29z8BmXWnbE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGkRAvaONrYYMZBAIesqWJY9cPCA1GtTIYCDbUt-A48VapTUqTCu1f46_jLnGyBU3Ay54i1ZcoOZ9__l19H4Q8Tbj0U6Adbmp44DLO-q40qXAN7G2eSYGDqKra5yHfP2bvx-F4hfxqcmEwrLLBxAqok1zjf-TgpAOVBzrihTvGhkV83hu-nv9wsYMUnrQ27TRqEzlIz36C-1a8Gu3BXD_z_eG7o7f7ru0w4GrgyaWb8rivOYtjyWLuY28s7FCnFGNCJUYh2WdGap-l3BgvkeFA-sIzgiVSSxAM4LnXyHURhH1cY2LcOnuAI5zbVL1A9HesZWzP8yzdxpo0HnYcurAVVh0D2n2hN5_mxWWk98_YzQub4XCV3LIslu7WZrdGVtLsNlmzOFHQF7aY9cs7pPyI6U369GwG8kW5yPGKpwUFxcwWWvUIpMsZxuhqHAJt0nldV4oCOaXJeVQTzQ2dAjhRAz5-XkwKOsnoBBNccm3pf0lngHx3yfGVzMM90stAs-uEDgCCBgr7foKvJXUSe7ECTtJnWhvuK88hQaP0SNsy6NiNYxpVZ3sC3KFahxFOVWSnyiFue9e8LgPyD_k3OJ-tLBbxrn7IFyeRxYSIqyBJlCcUBx7nCREr-ERfSKGwRn_IHbKF1hDVGbEtFEW7IcMwWhlIhzypJLCQR4ZL4kQtiyIaffr2H0Jfv3SEnlshk4M6tLLZGfBNWCCsI7nZkQQ40p3hdbTdRitFdL5w4c7Gni8fftwO40Mx-i9L86WVCTGl2iH3a_NvNevLQYi9lhwiOgujo_ruSDY5reqohxK07PEHf3-tLXIDgCb6MDo82CA3gS8P6kjBTdIrF8v0IXDSMn5ULX5Kvl812vwGt2eh5w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mesenchymal+stromal+cells+from+human+umbilical+cord+prevent+the+development+of+lung+fibrosis+in+immunocompetent+mice&rft.jtitle=PloS+one&rft.au=Moroncini%2C+Gianluca&rft.au=Paolini%2C+Chiara&rft.au=Orlando%2C+Fiorenza&rft.au=Capelli%2C+Chiara&rft.date=2018-06-01&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=13&rft.issue=6&rft.spage=e0196048&rft_id=info:doi/10.1371%2Fjournal.pone.0196048&rft.externalDBID=ISR&rft.externalDocID=A541074939
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon